BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Innovations in Care

We provide access to support and programs that empower the lives of people living with neuromuscular diseases.

MDA Engage - Minneapolis

Saturday, September 23, 2023MDA Engage Logo
9:00am - 4:30pm
McNamara Alumni Center
200 SE Oak Street, Minneapolis, MN 55455

 

 

Watch On-Demand Here

MDA is pleased to have Drs. Peter Karachunski and Peter Kang, Co-Directors of the Paul and Sheila Wellstone Muscular Dystrophy Center at the University of Minnesota, presenting the Keynote Session.

Headshot of Peter Karachunski, MD
Peter Karachunski, MD
Associate Professor and Clinical Director
Paul and Sheila Wellstone Muscular Dystrophy Center
University of Minnesota

Headshot of Peter Kang
Peter Kang, MD
Professor and Vice Chair of Research
Director, Paul and Sheila Wellstone Muscular Dystrophy Center
University of Minnesota

Sessions:

Click here for the full agenda

 

Thank you to our symposium supporters:

 

MDA Thanks our sponsors:

  • Edgewise Therapeutics
  • PTC Therapeutics
  • Sarepta